Thrombosis and Haemostasis, Table of Contents Thromb Haemost 2003; 90(01): 157DOI: 10.1055/s-0037-1613613 Letters to the Editor Schattauer GmbH Elevated erythrocyte aggregation as a predisposing factor to aspirin resistance Halûk Demiroglu Recommend Article Abstract Buy Article Full Text References References 1 McKee SA, Sane DC, Deliargyris EN. Aspirin resistance in cardiovascular disease: a review of prevalenve, mechanisms, and clinical significance. Thromb Haemost 2002; 88: 711-5. 2 Resch KL, Ernst E, Matrai A. et al. Can rheologic variables be of prognostic relevance in arteriosclerotic disease?. Angiology 1991; 41: 963-70. 3 Stoltz JF, Donner M. Hemorheology: importance of erythrocyte aggregation. Clin Hemorheol 1987; 7: 15-23. 4 Demiroglu H. The importance of erythrocyte aggregation in blood rheology: considerations on the pathophysiology of thrombotic disorders. Blood 1997; 89: 4236 5 Demiroglu H, Barista I, Dundar S. The effects of age and menopause on erythrocyte aggregation. Thromb Haemost 1997; 77: 404 6 Demiroglu H, Yalcin S, Buyukasik Y. et al. Increased erythrocyte aggregation as an indicator for an aggressive clinical course in Behçet’s disease: a prospective study. Ann Rheum Dis 1998; 57: 694-6. 7 Demiroglu H, Gurlek A, Barista I. Enhanced erythrocyte aggregation in type 2 diabetes with late complications. Exp Clin Endocrinol Diabetes 1999; 107: 35-9. 8 Demiroglu H, Barista I, Dundar S. Erythrocyte aggregability in patients with coronary heart disease. Clin Hemorheol 1996; 16: 313-7. 9 Hayakawa M, Kuzuya F. Effects of ticlopidine on erythrocyte aggregation in thrombotic disorders. Angiology 1991; 42: 747-53. 10 Mehta SR, Yusuf S. The Clopidogrel in Unstable angina to prevent Recurrent events (CURE) Study Investigators. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J 2000; 24: 2033-41.
